Fri, Jul 11, 2014, 7:57 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Hemispherx Biopharma, Inc. Message Board

  • sixofus6 sixofus6 Nov 3, 2009 9:39 AM Flag

    sold - i see lawsuits coming

    Carter misstated FDA process to raise more money. that's flirting with disaster. if he's not fired don't put any hope or money in this 'till the smoke clears.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What the company's LAWYERS don't or CAN'T EXPLAIN, however, IS WHY Carter was TELLING INVESTORS that the Ampligen FDA FILING WAS COMPLETE and on track WHILE the company's SEC FILINGS were STATING the total OPPOSITE. when your lawyers are tongue tied you are in serious trouble. damage control is the best they can do. i would have liked to see this through but time is money. GLTA see ya

    • From my perspective, The Street article is bullshit.

      The period of time, when HEB's stock SP rose and Carter naturally and correctly took advantage of it, there were no further requests for data or anything else from the FDA.

      This occured later in the Sept-October 09 time frame. I am not exactly sure of the date, but Carter announced it verbally in a conference call. If you all recall, the stock SP began it's dive at that point from the 2.20+ range to where it was prior to the ADAM article at 1.35 or so.

      At no time, from what I can see, did Carter mislead anyone. he did exactly what he was required to do when he became aware of regulatory changes and or requests.

      Not that it makes any difference mind you, but these exxagerated accusations should not be allowed to proliferate.

      • 1 Reply to madaniels57
      • Don't go parsing Feuerstein. For all intents, today's article claims quite clearly that Carter lied with respect to issues material to his fiduciary responsibilities.

        What's odd is that Feuerstein has stuck his neck out, but Carter seems reluctant to execute the chop - i.e. take Feuerstein to court and sue him silly.

        Why is that? If it went to court, all material documents - FDA or otherwise - would be subpoenaed. The truth would come out. If Feuerstein is wrong, he's screwed. Dr. Bill has no love for Adam - and that's clear from his broadsides fired in response to past AF articles on HEB - so why does Carter persist in tolerating AF's "hack" pieces and the ensuing collapse of the PPS??

        What's Carter waiting for? For HEB to be relegated to the pink sheets and penny stock purgatory? In any event, he has a very odd way of manifesting the courage of his convictions or the survival instincts of his company.

    • You picked up on that after 87 posts, inclusive of the dndn board??? You are my hero !

    • Go back and read my post on FDA Tuturiol Approval process....what has taken place today is outlined EXACTLY within the possibilities of an FDA NDA process....

    • He didn't misstate anything....you simply cannot prove that. Any lawsuits will be quickly thrown out after all facts are considered...you bashers simply are working on circumstantial bs.

      • 1 Reply to stocwach
      • "He didn't mistate anything."

        That is B.S. on par with Carter.

        "Monday's statement was likely crafted by Hemispherx's lawyers as a way to help CEO Bill Carter wiggle out of public statements he made in May and June claiming the Ampligen application to the U.S. Food and Drug Administration to be complete. Carter insisted regulators weren't asking for any additional information on Ampligen. Carter's made these statements both before and immediately after the FDA approval decision date for Ampligen on May 25, which came and went without any word from the agency. We now know that Carter's statements were demonstrably false."

 
HEB
0.2972+0.0072(+2.48%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.